Stock Details
BHC is Bausch Health Companies Inc.'s stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 11.34$. Average daily volumn in 3 months 7.58M. Market cap 3.27B



Stock symbol : BHC. Exchange : NYSE. Currency : USD
Lastest price : 9.05$. Total volume : 4.69M. Market state PRE
Click reload if you want to check the lastest price on market!!!

Bausch Health Companies Inc. (BHC)
Last Price
9.05$
Change
0.52
Volume
4.69M

Previous Close8.53
Open8.39
Day Range8.24-9.07
Bid8.61 x 3.2k
Ask0.00 x 1.2k
Volume4.69M
Average Volume7.58M
Market Cap3.27B
Beta1.66
52 Week Range6.88-30.01
Trailing P/EN/A
Foward P/E1.53
Dividend (Yield %)N/A
Ex-Dividend Date2010-11-10



Financial Details


According to Bausch Health Companies Inc.'s financial reports the company's revenue in 2021 were 8.43B an increase(0%) over the years 2020 revenue that were of 8.03B. In 2021 the company's total earnings were -948M while total earnings in 2020 were -560M( +69.29%).


Loading ...



Organization

Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment offers products with a focus on the vision care, surgical, and consumer, surgical... , and ophthalmic pharmaceuticals products. The Salix segment provides gastroenterology products in the United States. The International Rx segment offers Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Ortho Dermatologics segment provides dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment offers pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

Market Cap:
3.27B
Revenue:
8.43B
Total Assets:
29.2B
Total Cash:
582M


News about "Bausch Health Companies Inc."

bausch-health-companies-inc-nysebhc-given-consensus-recommendation-of-moderate-buy-by-brokerages-image

Bausch Health Companies Inc. (NYSE:BHC) Given Consensus Recommendation of โ€œModerate Buyโ€ by Brokerages

Source from : Defense World - 3 days ago

Shares of Bausch Health Companies Inc. (NYSE:BHC โ€“ Get Rating) have been assigned a consensus recommendation of โ€œModerate Buyโ€ from the ten ratings firms that are covering the firm, Marketbeat Ratings ...See details»


Analyst Predictions On Bausch Health Companies Inc.โ€™s (NYSE: BHC) Future Growth

Source from : stocksregister - 1 days ago

Bausch Health Companies Inc. (NYSE:BHC) price is hovering higher on Tuesday, July 05, jumping 2.46% above its previous close. >> 5 Best Growth Stocks for 2022 << >> 5 Best Growth Stocks for 2022 << A ...See details»


Bausch Health Companies Inc. (BHC) Volatility Hits 8.01% โ€“ Hereโ€™s What A Good Investor Should Do

Source from : stocksregister - 5 days ago

Bausch Health Companies Inc. (NYSE:BHC) concluded the trading at $8.36 on Thursday, June 30 with a fall of -1.76% from its closing price on previous day. Taking a look at stock we notice that its last ...See details»


right-now-may-be-the-best-buy-in-window-for-bausch-health-companies-inc-bhc-image

Right Now May Be the Best Buy-In Window for Bausch Health Companies Inc. (BHC)

Source from : investchronicle - 14 days ago

Bausch Health Companies Inc. (BHC) is priced at $7.30 after the most recent trading session. At the very opening of the session, the stock price was $7.46 and reached a high price of $7.60, prior to ...See details»


Bausch Health Companies Inc.: End of an Era as Papa Leaves Bausch's Board; Shares Still Trade Below FVE After 18% Gain

Source from : YAHOO!Finance - 12 days ago

Find the latest Bausch Health Companies Inc. (BHC) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance ...See details»


Bausch Health Companies (NYSE:BHC) Reaches New 52-Week Low at $7.02

Source from : Defense World - 12 days ago

Bausch Health Companies Inc. (NYSE:BHC โ€“ Get Rating) shares hit a new 52-week low during mid-day trading on Wednesday . The stock traded as low as $7.02 and last traded at $7.19, with a volume of ...See details»


Bausch Health Companies (NYSE:BHC) Shares Gap Up to $7.27

Source from : ETF Daily News - 10 days ago

Bausch Health Companies had a negative return on equity of 649.29% and a negative net margin of 4.89%. The company had revenue of $1.92 billion during the quarter, compared to analysts ...See details»


Bausch Health Companies Inc - Stock Quote BHC

Source from : Morningstar%2c Inc. - 12 days ago

Bausch Health shares rose over 18% on June 24 as the company announced the departure of previous CEO Joseph C. Papa from the board of directors. According to the press release, Papaโ€™s ...See details»


Bausch Health Announces 2022 Annual Meeting of Shareholder Results, Updates to its Board of Directors

Source from : Business Insider - 12 days ago

LAVAL, QC, June 23, 2022 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced the results of its 2022 annual meeting of shareholders and ...See details»


Bausch Health Companies Inc stock boosted on Friday.

Source from : The Globe and Mail - 12 days ago

Detailed price information for Bausch Health Companies Inc (BHC-T) from The Globe and Mail including charting and trades.See details»


Why Bausch Health Stock Is Bolting Higher Today

Source from : Nasdaq - 12 days ago

Shares of the specialty pharmaceutical company Bausch Health Companies (NYSE: BHC) are surging today in response to the news that Joseph Papa has resigned from the board of directors effective ...See details»


Bausch Health names hedge fund manager John Paulson as chairperson

Source from : Times Colonist - 12 days ago

formerly known as Valeant Inc., is seen in Laval, Que., Wednesday, February 20, 2019. Bausch Health Companies Inc. says hedge fund manager John Paulson has been named chairperson of its board of ...See details»


Bausch Health Issues Form 8-K for 2022 Annual Meeting of Shareholders Presentation

Source from : Business Insider - 12 days ago

LAVAL, QC, June 21, 2022 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced the Company is providing a presentation on its business ...See details»


bausch-health-names-hedge-fund-billionaire-paulson-chairman-image

Bausch Health Names Hedge Fund Billionaire Paulson Chairman

Source from : Yahoo Finance - 12 days ago

Bausch Health Cos. named hedge fund billionaire John Paulson as its new chairman, replacing Joseph Papa, who resigned Thursday.Most Read from BloombergSupreme Court Overturns Roe, Transforming ...See details»